Ignite Creation Date:
2025-12-24 @ 4:18 PM
Ignite Modification Date:
2026-04-18 @ 4:55 PM
Study NCT ID:
NCT05037266
Status:
TERMINATED
Last Update Posted:
2025-02-10
First Post:
2021-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen
Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-20
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-29
Completion Date Type:
ACTUAL
First Submit Date:
2021-09-06
First Submit QC Date:
None
Study First Post Date:
2021-09-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-06
Last Update Post Date:
2025-02-10
Last Update Post Date Type:
ACTUAL